Haemonetics CTO Anila Lingamneni to depart on November 1, 2024

HAEMONETICS CORP

Anila Lingamneni, EVP and Chief Technology Officer, will leave Haemonetics effective November 1, 2024.
No replacement for the CTO role has been announced.
The company expressed gratitude for Ms. Lingamneni's contributions and wished her success.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Anila Lingamneni

Executive Vice President, Chief Technology Officer

HAE · HAEMONETICS CORP

Effective: 2024-11-01
Filed: September 16, 2024, 7:59 PM ET

Anila Lingamneni, Executive Vice President, Chief Technology Officer, will leave Haemonetics Corporation (the “Company”) on November 1, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Anila Lingamneni departed as Executive Vice President, Chief Technology Officer at HAEMONETICS CORP.

Action: will leave
Role: Executive Vice President, Chief Technology Officer

Exact text from the filing

Anila Lingamneni, Executive Vice President, Chief Technology Officer, will leave Haemonetics Corporation (the “Company”) on November 1, 2024.

View on SEC.gov

HAEMONETICS CORP filing history →

Source: SEC EDGAR

accession 0000313143-24-000056

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.